tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Li Q et al. Development and validation of a sensitive LC-MS/MS method for determination of tacrolimus on dried blood spots. 2013 Biomed. Chromatogr. pmid:22893355
Vassal O et al. [Bacterial parotitis in an immunocompromised patient in adult ICU]. 2013 Ann Fr Anesth Reanim pmid:23948025
Yoshikawa Y et al. [Pre-evening meal administration of tacrolimus improved refractory ocular symptoms in two young children with latent general myasthenia gravis]. 2013 No To Hattatsu pmid:23951946
Preidl RH et al. Clopidogrel reduces post-transplant obliterative bronchiolitis. 2013 Transpl. Int. pmid:23952051
Wimmer CD et al. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients. 2013 Transpl. Int. pmid:23952102
Mignogna MD et al. Clinical behaviour and long-term therapeutic response in orofacial granulomatosis patients treated with intralesional triamcinolone acetonide injections alone or in combination with topical pimecrolimus 1%. 2013 J. Oral Pathol. Med. pmid:22784292
Ladizinski B et al. Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University. 2013 J. Am. Acad. Dermatol. pmid:23375454
Naora Y et al. Expression analysis of XPhyH-like during development and tail regeneration in Xenopus tadpoles: possible role of XPhyH-like expressing immune cells in impaired tail regenerative ability. 2013 Biochem. Biophys. Res. Commun. pmid:23313512
Nonaka K et al. Intractable membranous lupus nephritis showing selective improvement of subepithelial deposits with tacrolimus therapy: a case report. 2013 Clin. Nephrol. pmid:22541676
Dumortier J et al. Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients. 2013 Liver Transpl. pmid:23483701
Provenzani A et al. Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients. 2013 World J. Gastroenterol. pmid:24409044
Brown RS et al. Topical tacrolimus with custom trays in the treatment of severe oral chronic graft-versus-host disease refractory to a potent topical steroid therapy: a case report. 2013 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:23102802
Giannelli V et al. Conversion from twice-daily to once-daily Tacrolimus administration in liver transplant patient: results of long term follow-up. 2013 Eur Rev Med Pharmacol Sci pmid:24174352
van den Hoogen MW et al. Insulin requirement after a renal transplant in patients with type 2 diabetes: the choice of calcineurin inhibitors. 2013 Exp Clin Transplant pmid:23432070
Westland T et al. Treatment of atopic keratoconjunctivitis in patients with atopic dermatitis: is ocular application of tacrolimus an option? 2013 J Eur Acad Dermatol Venereol pmid:23106347
Shi Y et al. Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients. 2013 Gene pmid:23107770
Johannesson L et al. Preclinical report on allogeneic uterus transplantation in non-human primates. 2013 Hum. Reprod. pmid:23108346
López E et al. Immunophilins are involved in the altered platelet aggregation observed in patients with type 2 diabetes mellitus. 2013 Curr. Med. Chem. pmid:23432586
Chung BY et al. The proactive treatment of atopic dermatitis with tacrolimus ointment in Korean patients: a comparative study between once-weekly and thrice-weekly applications. 2013 Br. J. Dermatol. pmid:23110605
Du J et al. Long-term efficacy and safety of tacrolimus ointment in the treatment of vitiligo. 2013 J. Dermatol. pmid:24111918
Khanmoradi K et al. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients. 2013 Exp Clin Transplant pmid:23432665
Arora RB et al. FK506 attenuates intracerebroventricular streptozotocin-induced neurotoxicity in rats. 2013 Behav Pharmacol pmid:26057771
De Simone C et al. Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study. 2013 J Eur Acad Dermatol Venereol pmid:22788697
Pan F et al. [Protective effect of tacrolimus postconditioning on oxidative stress injury provoked by spinal cord ischemia-reperfusion in rats]. 2013 Zhonghua Yi Xue Za Zhi pmid:24548402
Uchino M et al. Topical tacrolimus therapy for antibiotic-refractory pouchitis. 2013 Dis. Colon Rectum pmid:24022534
de Jonge H et al. Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism. 2013 Pharmacogenomics pmid:24024898
Mesar I et al. Rescue therapy with sirolimus in a renal transplant recipient with tacrolimus-induced hepatotoxicity. 2013 Ren Fail pmid:24028307
Shihab FS et al. Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study. 2013 Am. J. Transplant. pmid:23167508
Dong QE et al. [Inhibitory effects of tacrolimus on effector T cells from patients with severe aplastic anemia]. 2013 Zhonghua Yi Xue Za Zhi pmid:24028719
Bayer J et al. Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model. 2013 J. Thorac. Cardiovasc. Surg. pmid:24029291
Rojas LE et al. Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation. 2013 Pharmacogenet. Genomics pmid:23873120
Bourdeaux C et al. Prope tolerance after pediatric liver transplantation. 2013 Pediatr Transplant pmid:23171043
Jones AC et al. Phage p1-derived artificial chromosomes facilitate heterologous expression of the FK506 gene cluster. 2013 PLoS ONE pmid:23874942
Eurich D et al. YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease. 2013 J. Gastroenterol. Hepatol. pmid:22989351
Prucha H et al. Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema. 2013 Expert Opin Drug Metab Toxicol pmid:23876065
Miwa Y et al. Depression is improved when low-dose tacrolimus is given to rheumatoid arthritis patients showing an inadequate response to biologic agents. 2013 Mod Rheumatol pmid:22990336
Kim CH et al. 850nm light-emitting-diode phototherapy plus low-dose tacrolimus (FK-506) as combination therapy in the treatment of Dermatophagoides farinae-induced atopic dermatitis-like skin lesions in NC/Nga mice. 2013 J. Dermatol. Sci. pmid:23810774
Chaabane A et al. Limited sampling strategy of mycophenolic acid in adult kidney transplant recipients: influence of the post-transplant period and the pharmacokinetic profile. 2013 J Clin Pharmacol pmid:23813362
Ma MK et al. Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment. 2013 Ren Fail pmid:23815459
Klintmalm G and O'Farrelly C Taking the rap: multiple effects of blocking mammalian target of rapamycin. 2013 Hepatology pmid:22767219
Rickels MR et al. Improvement in insulin sensitivity after human islet transplantation for type 1 diabetes. 2013 J. Clin. Endocrinol. Metab. pmid:24085506
Renner B et al. Cyclosporine induces endothelial cell release of complement-activating microparticles. 2013 J. Am. Soc. Nephrol. pmid:24092930
Faralli JA et al. Dexamethasone increases αvβ3 integrin expression and affinity through a calcineurin/NFAT pathway. 2013 Biochim. Biophys. Acta pmid:24100160
Michel S et al. Renal recovery after conversion to an everolimus-based immunosuppression in early and late heart transplant recipients: a 12-month analysis. 2013 Exp Clin Transplant pmid:24128136
Kim Y et al. Patients with persistent new-onset diabetes after transplantation have greater weight gain after kidney transplantation. 2013 J. Korean Med. Sci. pmid:24133345
Niu YJ et al. Establishment of tacrolimus-induced diabetes in rat model and assessment of clinical treatments for post-transplant diabetes mellitus in liver transplant recipients. 2013 Clin. Lab. pmid:24133918
Azevedo LS et al. Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors. 2013 Transpl Infect Dis pmid:24134688
Landy J et al. Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centres. 2013 J Crohns Colitis pmid:23623737
Vichyanond P and Kosrirukvongs P Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis. 2013 Curr Allergy Asthma Rep pmid:23625179
Wang Y et al. Micelles of methoxy poly(ethylene glycol)-poly(epsilon-caprolactone) as a novel drug delivery vehicle for tacrolimus. 2013 J Biomed Nanotechnol pmid:23627041
Wei H et al. Effects of traditional chinese medicine Wuzhi capsule on pharmacokinetics of tacrolimus in rats. 2013 Drug Metab. Dispos. pmid:23628674
Rickels MR et al. Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol. 2013 Diabetes pmid:23630300
Axelsson J et al. Scavengers of reactive oxygen species, paracalcitol, RhoA, and Rac-1 inhibitors and tacrolimus inhibit angiotensin II-induced actions on glomerular permeability. 2013 Am. J. Physiol. Renal Physiol. pmid:23657856
Pan F et al. Tacolimus postconditioning alleviates apoptotic cell death in rats after spinal cord ischemia-reperfusion injury via up-regulating protein-serine-threonine kinases phosphorylation. 2013 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:24337847
Harikishore A et al. Adamantyl derivative as a potent inhibitor of Plasmodium FK506 binding protein 35. 2013 ACS Med Chem Lett pmid:24900611
Selden NR et al. Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis. 2013 J Neurosurg Pediatr pmid:23581634
Yao W et al. Aβ induces acute depression of excitatory glutamatergic synaptic transmission through distinct phosphatase-dependent mechanisms in rat CA1 pyramidal neurons. 2013 Brain Res. pmid:23583290
Hill JA et al. Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations. 2013 PLoS Genet. pmid:23593013
Tszyrsznic W et al. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23584041
Lee Sr et al. Angiotensinogen polymorphisms and post-transplantation diabetes mellitus in Korean renal transplant subjects. 2013 Kidney Blood Press. Res. pmid:23594830
Santoro AB et al. CYP3A5 genotype, but not CYP3A4*1b, CYP3A4*22, or hematocrit, predicts tacrolimus dose requirements in Brazilian renal transplant patients. 2013 Clin. Pharmacol. Ther. pmid:23588314
Riegersperger M et al. Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipients. 2013 Transplantation pmid:23594858
De Simone P et al. Everolimus with reduced tacrolimus in liver transplantation. 2013 Am. J. Transplant. pmid:23601137
Kumar AJ et al. Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation. 2013 Biol. Blood Marrow Transplant. pmid:23635453
Israni AK et al. Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics. 2013 Transpl. Int. pmid:23879408
Casanova JR et al. Rapid hippocampal network adaptation to recurring synchronous activity--a role for calcineurin. 2013 Eur. J. Neurosci. pmid:23879713
Huang D et al. Genome-scale metabolic network guided engineering of Streptomyces tsukubaensis for FK506 production improvement. 2013 Microb. Cell Fact. pmid:23705993
Ban YH et al. Characterization of FK506 biosynthetic intermediates involved in post-PKS elaboration. 2013 J. Nat. Prod. pmid:23706030
Sanz-Marco E et al. Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops. 2013 J Ocul Pharmacol Ther pmid:23947579
Pamuk F et al. Effects of tacrolimus and nifedipine, alone or in combination, on gingival tissues. 2013 J. Periodontol. pmid:23289868
Eguchi R et al. FK506 induces endothelial dysfunction through attenuation of Akt and ERK1/2 independently of calcineurin inhibition and the caspase pathway. 2013 Cell. Signal. pmid:23707520
Fitzgerald RT et al. Isolated leptomeningeal enhancement in tacrolimus-associated posterior reversible encephalopathy syndrome. 2013 Pediatr. Neurol. pmid:23290027
van Maarseveen EM et al. Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot study. 2013 Transplantation pmid:23250333
Hou Q et al. Pharmacokinetic interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome. 2013 Eur. J. Clin. Pharmacol. pmid:23765408
Shivaswamy V et al. Metformin improves immunosuppressant induced hyperglycemia and exocrine apoptosis in rats. 2013 Transplantation pmid:23250335
Eun SC et al. Prolongation of the rat composite tissue allograft survival by the combination of tolerogenic immature dendritic cells and short-term treatment with FK506. 2013 Transplant. Proc. pmid:23769045
Xu H et al. Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance. 2013 Transplantation pmid:23250336
Han N et al. Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients. 2013 Eur. J. Clin. Pharmacol. pmid:22660440
Oteo I et al. Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction. 2013 Eur. J. Clin. Pharmacol. pmid:22660442
Sarkar S et al. Tacrolimus induced diabetic ketoacidosis in nephrotic syndrome. 2013 Indian J Pediatr pmid:22660906
Bashratyan R et al. Insulinoma-released exosomes activate autoreactive marginal zone-like B cells that expand endogenously in prediabetic NOD mice. 2013 Eur. J. Immunol. pmid:23817982
Zlatic SA et al. Chemical-genetic disruption of clathrin function spares adaptor complex 3-dependent endosome vesicle biogenesis. 2013 Mol. Biol. Cell pmid:23761069
Yin H et al. Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin. 2013 PLoS ONE pmid:23762423
López E et al. FKBP52 is involved in the regulation of SOCE channels in the human platelets and MEG 01 cells. 2013 Biochim. Biophys. Acta pmid:23228564
Tie X et al. NFAT1 is highly expressed in, and regulates the invasion of, glioblastoma multiforme cells. 2013 PLoS ONE pmid:23762456
Knops N et al. From gut to kidney: transporting and metabolizing calcineurin-inhibitors in solid organ transplantation. 2013 Int J Pharm pmid:23711732
Mourer JS et al. Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients. 2013 Transplantation pmid:23715049
Nagaraja P et al. Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation. 2013 Transpl. Int. pmid:23230898
Fujita Y et al. Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents. 2013 J Clin Pharm Ther pmid:22971159
Musso CG et al. Furosemide test in stage III-chronic kidney disease and kidney transplant patients on tacrolimus. 2013 Int Urol Nephrol pmid:23233031
Yang CH et al. Effect of tacrolimus on myocardial infarction is associated with inflammation, ROS, MAP kinase and Akt pathways in mini-pigs. 2013 J. Atheroscler. Thromb. pmid:22972310
Sofue T et al. Excess fluid distribution affects tacrolimus absorption in peritoneal dialysis patients. 2013 Clin. Exp. Nephrol. pmid:23269423
Inoue T et al. The efficacy of oral tacrolimus in patients with moderate/severe ulcerative colitis not receiving concomitant corticosteroid therapy. 2013 Intern. Med. pmid:23291669
Sommers CD et al. Analyses of marketplace tacrolimus drug product quality: bioactivity, NMR and LC-MS. 2013 J Pharm Biomed Anal pmid:23917038
Barbas AS et al. Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. 2013 Am. J. Transplant. pmid:23331705
Noll BD et al. Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsies. 2013 Ther Drug Monit pmid:23921430
Rice SA et al. Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease. 2013 BMC Res Notes pmid:23331739
Kanda J et al. Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. 2013 Bone Marrow Transplant. pmid:23334274
Gül FC et al. The comparison of the impact of ghrelin and tacrolimus on vitreous cytokine levels in an experimental uveitis model. 2013 Graefes Arch. Clin. Exp. Ophthalmol. pmid:23334350
Martina MR et al. The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a New class of nanomolar FKBP12 ligands. 2013 J. Med. Chem. pmid:23301792